News
Check all IrsiCaixa scientific news in just one click.
SARS-CoV-2
Vaccines
Antibodies
HIPRA’s COVID-19 vaccine induces a good neutralising antibody response against the new subvariants of Omicron
Microbiome
SARS-CoV-2
HIV